<code id='1B8D5D0163'></code><style id='1B8D5D0163'></style>
    • <acronym id='1B8D5D0163'></acronym>
      <center id='1B8D5D0163'><center id='1B8D5D0163'><tfoot id='1B8D5D0163'></tfoot></center><abbr id='1B8D5D0163'><dir id='1B8D5D0163'><tfoot id='1B8D5D0163'></tfoot><noframes id='1B8D5D0163'>

    • <optgroup id='1B8D5D0163'><strike id='1B8D5D0163'><sup id='1B8D5D0163'></sup></strike><code id='1B8D5D0163'></code></optgroup>
        1. <b id='1B8D5D0163'><label id='1B8D5D0163'><select id='1B8D5D0163'><dt id='1B8D5D0163'><span id='1B8D5D0163'></span></dt></select></label></b><u id='1B8D5D0163'></u>
          <i id='1B8D5D0163'><strike id='1B8D5D0163'><tt id='1B8D5D0163'><pre id='1B8D5D0163'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          leisure time

          author:focus    - browse:18119
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus